The single-point insulin sensitivity estimator (SPISE) index is a strong predictor of abnormal glucose metabolism in overweight/obese children: a long-term follow-up study

J Endocrinol Invest. 2022 Jan;45(1):43-51. doi: 10.1007/s40618-021-01612-6. Epub 2021 Jun 17.

Abstract

Purpose: To investigate the relationship between the single-point insulin sensitivity estimator (SPISE) index, an insulin sensitivity indicator validated in adolescents and adults, and metabolic profile in overweight/obese children, and to evaluate whether basal SPISE is predictive of impaired glucose regulation (IGR) development later in life.

Methods: The SPISE index (= 600 × HDL0.185/Triglycerides0.2 × BMI1.338) was calculated in 909 overweight/obese children undergoing metabolic evaluations at University of Cagliari, Italy, and in 99 normal-weight, age-, sex-comparable children, selected as a reference group, together with other insulin-derived indicators of insulin sensitivity/resistance. 200 overweight/obese children were followed-up for 6.5 [3.5-10] years, data were used for longitudinal retrospective investigations.

Results: At baseline, 96/909 (11%) overweight/obese children had IGR; in this subgroup, SPISE was significantly lower than in normo-glycaemic youths (6.3 ± 1.7 vs. 7 ± 1.6, p < 0.001). The SPISE index correlated positively with the insulin sensitivity index (ISI) and the disposition index (DI), negatively with age, blood pressure, HOMA-IR, basal and 120 min blood glucose and insulin (all p values < 0.001). A correlation between SPISE, HOMA-IR and ISI was also reported in normal-weight children. At the 6.5-year follow-up, lower basal SPISE-but not ISI or HOMA-IR-was an independent predictor of IGR development (OR = 3.89(1.65-9.13), p = 0.002; AUROC: 0.82(0.72-0.92), p < 0.001).

Conclusion: In children, low SPISE index is significantly associated with metabolic abnormalities and predicts the development of IGR in life.

Keywords: Childhood obesity; Impaired glucose regulation; Insulin resistance; Insulin-sensitivity index; SPISE; Screening.

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Blood Glucose / metabolism*
  • Body Mass Index
  • Female
  • Glucose Metabolism Disorders* / blood
  • Glucose Metabolism Disorders* / diagnosis
  • Glucose Metabolism Disorders* / epidemiology
  • Glucose Metabolism Disorders* / metabolism
  • Humans
  • Insulin Resistance*
  • Insulin Secretion
  • Italy / epidemiology
  • Male
  • Metabolome*
  • Overweight* / diagnosis
  • Overweight* / epidemiology
  • Overweight* / metabolism
  • Pediatric Obesity* / diagnosis
  • Pediatric Obesity* / epidemiology
  • Pediatric Obesity* / metabolism
  • Predictive Value of Tests
  • Puberty / metabolism
  • Risk Factors
  • Triglycerides / blood

Substances

  • Blood Glucose
  • Triglycerides